Valeo Financial Advisors’s CONMED CNMD Stock Holding History

Valeo Financial Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	-$1K	–	1691
2020 Q2	$1K	Buy	+9	New	+$626	﹤0.01%	1857

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Valeo Financial Advisors's CNMD Position: Q3 2020 in Review

Valeo Financial Advisors sold out of CONMED (CNMD) in Q3 2020, closing a stake of 9 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in CNMD in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

Valeo Financial Advisors reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
Valeo Financial Advisors sold 9 CONMED shares in Q3 2020, an estimated $1K.
Valeo Financial Advisors first reported a position in CONMED in Q2 2020 and held it in 1 quarter.
Valeo Financial Advisors's CONMED position peaked at $1K in Q2 2020.
240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.